A federal deadline ending sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to ...

After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

(CNN) – The crackdown on off-brand weight loss and diabetes treatment drugs is about to take effect, meaning supplies for the treatments are likely to tighten. A federal deadline to halt sales of the ...

The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

Italy’s Moltiply Group (MOL.MI) has filed a €2.97 billion ($3.34 billion) lawsuit against Alphabet Inc.'s Google, accusing the tech giant of abusing its dominant market position to the ...

Meta Platforms has secured a $168 million verdict against Israeli surveillance company NSO Group, marking a historic legal victory in the global fight against commercial spyware. The ruling ...